Why it matters

Why does kidney function testing need tighter standardisation in nephrology trials?
Most nephrology endpoints are built around estimated glomerular filtration rate (eGFR), calculated from serum creatinine, so any variation in how that sample is processed and analysed across sites can shift the number the entire trial depends on. Standardised, calibrated POCT and laboratory equipment across every site is what keeps that calculation comparable trial-wide.

Dialysis-dependent patients change the trial's logistics, not just its protocol
A meaningful share of nephrology trial participants are on dialysis, which limits how far and how often they can travel for study visits. That's pushing more nephrology trials toward decentralised elements and equipment that can be deployed closer to where dialysis patients already are, rather than requiring an additional trip to a research site.

Nephrology increasingly overlaps with cardiovascular and metabolic trials
The rise of SGLT2 inhibitors and related therapies has blurred the line between nephrology, cardiovascular, and diabetes research, with many trials now tracking kidney, heart, and metabolic outcomes together. Teams working across this overlap need a supplier who can equip all three without treating them as separate projects.


What we do

Our global distribution network puts calibrated equipment on site for nephrology studies anywhere in the world, whenever it's needed. Kidney function testing covers POCT urine and blood analysers and incubators. Day-to-day site operations covers refrigerators, freezers, thermometers, temperature dataloggers, and scales. Everything is available fully calibrated and ready to use. If you require equipment supply for a nephrology study, get in touch.

Featured case study

Featured blog

Got a question?

Got a question?

Why partner with us?

Our 35+ years of experience with product knowledge, sourcing quality, regulatory intelligence and logistical knowhow makes us experts in what we do.

We take care of details – providing reassurance and saving you time and money from end-to-end of your clinical trial.

More about us

More therapeutic areas

See all therapeutic areas

References

  1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073222/#:~:text=Chronic%20kidney%20disease%20is%20a,amounting%20to%20%3E800%20million%20individuals